Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Vaisman

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Thyroid Research|September 10, 2011
Thyroid carcinoma in children and adolescents-systematic review of the literatureFernanda Vaisman, Rossana Corbo, Mario Vaisman
Endocrine-Related Cancer|August 27, 2015
A new appraisal of iodine refractory thyroid cancerFernanda Vaisman, Denise P Carvalho, Mario Vaisman
European Thyroid Journal|May 1, 2014
Management of subclinical hypothyroidism: the thyroidologists' viewSimon H S Pearce, Mario Vaisman, Jean-Louis Wemeau
Thyroid Research|December 25, 2013
Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjectsRosita Fontes, Claudia Regina Coeli, Fernanda Aguiar, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 23, 2008
TSH levels associated with slimming pill use in a population-based study of Brazilian womenRosely Sichieri, Roseli Andrade, Jader Baima, et al.
Journal of Diabetes Research|July 13, 2016
Screening of Undiagnosed Hypothyroidism in Elderly Persons with Diabetes according to Age-Specific Reference Intervals for Serum Thyroid Stimulating Hormone and the Impact of Antidiabetes DrugsRosita Fontes, Patricia de Fatima Dos Santos Teixeira, Mario Vaisman
Clinical Nuclear Medicine|May 23, 2012
Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancerDaniel B Kendler, Fernanda Vaisman, Rossana Corbo, et al.
Cytogenetic and Genome Research|February 24, 2017
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive HistotypesGustavo C Penna, Fernanda Vaisman, Mario Vaisman, et al.
Frontiers in Endocrinology|September 9, 2015
Pheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesMarcia Helena Soares Costa, Tania M Ortiga-Carvalho, Alice Dutra Violante, et al.
Clinical Nuclear Medicine|August 7, 2013
Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatmentLuciana Souza Cruz Caminha, Denise Prado Momesso, Fernanda Vaisman, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Thyroid Research|September 10, 2011
Thyroid carcinoma in children and adolescents-systematic review of the literatureFernanda Vaisman, Rossana Corbo, Mario Vaisman
Endocrine-Related Cancer|August 27, 2015
A new appraisal of iodine refractory thyroid cancerFernanda Vaisman, Denise P Carvalho, Mario Vaisman
European Thyroid Journal|May 1, 2014
Management of subclinical hypothyroidism: the thyroidologists' viewSimon H S Pearce, Mario Vaisman, Jean-Louis Wemeau
Thyroid Research|December 25, 2013
Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjectsRosita Fontes, Claudia Regina Coeli, Fernanda Aguiar, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 23, 2008
TSH levels associated with slimming pill use in a population-based study of Brazilian womenRosely Sichieri, Roseli Andrade, Jader Baima, et al.
Journal of Diabetes Research|July 13, 2016
Screening of Undiagnosed Hypothyroidism in Elderly Persons with Diabetes according to Age-Specific Reference Intervals for Serum Thyroid Stimulating Hormone and the Impact of Antidiabetes DrugsRosita Fontes, Patricia de Fatima Dos Santos Teixeira, Mario Vaisman
Clinical Nuclear Medicine|May 23, 2012
Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancerDaniel B Kendler, Fernanda Vaisman, Rossana Corbo, et al.
Cytogenetic and Genome Research|February 24, 2017
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive HistotypesGustavo C Penna, Fernanda Vaisman, Mario Vaisman, et al.
Frontiers in Endocrinology|September 9, 2015
Pheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesMarcia Helena Soares Costa, Tania M Ortiga-Carvalho, Alice Dutra Violante, et al.
Clinical Nuclear Medicine|August 7, 2013
Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatmentLuciana Souza Cruz Caminha, Denise Prado Momesso, Fernanda Vaisman, et al.
Pageof 10